Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Good Morning! Latin America.
Press releases published on August 13, 2025
Vacuum Therapy Device Market is Expected to Hit USD 3.5 Billion by 2035 with a Remarkable 5.01% CAGR
EIN Presswire
·
August 13, 2025
Global Vacuum Therapy Device Market Set for Steady Growth as Chronic Wounds Rise and Technology Advances US, NY, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- The global Vacuum Therapy Device Market is experiencing sustained expansion, presenting …
Incontinence Devices and Ostomy Market is Forecasted to Reach USD 24.5 Billion By 2035, at CAGR of 3.84%
EIN Presswire
·
August 13, 2025
Global Incontinence Devices and Ostomy Market Poised for Substantial Growth Driven by Aging Populations and Product Innovation US, NY, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- The global Incontinence Devices and Ostomy Market is experiencing …
Luxury Home Decor Market Size Poised to Reach $216 Billion by 2034, Growing at 5.17% CAGR
EIN Presswire
·
August 13, 2025
The global luxury home decor market size was worth around USD 144.35 billion in 2024 and is predicted to grow to around USD 216.05 billion by 2034 PUNE, MAHARASHTRA, INDIA, August 13, 2025 /EINPresswire.com/ -- 🏠 Global Luxury Home Décor Market: Size, …
As Patient Trust in Doctors Plummets to 40%, This Physician's Human Touch Movement Goes Mainstream
EIN Presswire
·
August 13, 2025
With 70% of Patients Ready to Switch Providers, Dr. Parker-Curling's Bestselling C.A.R.E. Framework Spreads from The Caribbean to the United States and beyond SC, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- According to new research from NORC …
Rhythm of Hope Concert Delivers an Unforgettable Night at Woolwich Works
EIN Presswire
·
August 13, 2025
Sunday night, 10 August, Woolwich Works came alive with the vibrant sounds of the Rhythm of Hope Concert, The energy inside the venue was spectacular. LONDON, SURREY, UNITED KINGDOM, August 13, 2025 /EINPresswire.com/ -- Sunday night, 10 August, …
Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
August 13, 2025
Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the …
Applied Therapeutics Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT- …
Wesdome Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company”) today announced its financial results for the three and six months ended June 30, 2025 (“Q2 2025” and “H1 2025”). Preliminary operating …
Copa Holdings Announces Monthly Traffic Statistics for July 2025
GlobeNewswire
·
August 13, 2025
PANAMA CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Copa Holdings, S.A. (NYSE: CPA) today released preliminary passenger traffic statistics for July 2025: Copa Holdings (Consolidated) July 2025 July 2024 % Change ASM (mm) (1) 2,854.8 2,684.7 6.3% RPM (mm) …
SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 13, 2025
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold, triggering a $10M milestone payment from GSK. An additional $20M milestone will be triggered upon the six month anniversary of the new patient dosing; as …
Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider
GlobeNewswire
·
August 13, 2025
LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Jazz Pharmaceuticals for Modeyso™ (dordaviprone). It is indicated for the treatment of adult and …
Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
GlobeNewswire
·
August 13, 2025
Compelling new ARD-201 preclinical data informs optimized Phase 2 clinical development strategy of obesity programs: Phase 2 POWER trial of oral ARD-201 to focus on weight rebound in patients discontinuing GLP-1RA therapy, while Phase 2 STRENGTH trial to …
dLocal announces appointment of Chief Financial Officer
GlobeNewswire
·
August 13, 2025
MONTEVIDEO, Uruguay, Aug. 13, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”, “we”, “us”, and “our”) (NASDAQ:DLO), a technology - first payments platform, today announced the appointment of Guillermo López Pérez as Chief Financial Officer, who will join …
dLocal Reports 2025 Second Quarter Financial Results
GlobeNewswire
·
August 13, 2025
TPV at record high of US$9.2 billion, growing more than 50% YoY for the third consecutive quarter. Brazil and Mexico posted solid results, while growth remains fastest in the rest of our geographies, leading to increased diversification. Consistent …
Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs, supporting potential for improved protection against infection Enrolled approximately 5,000 participants in COVID-19 …
Codexis Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
Announces revenue of $15.3M vs $14.1M analyst consensus estimate Six presentations featured ECO Synthesis® platform at 2025 TIDES USA annual meeting, including three from leading CDMO collaborators $27.3M raised via ATM facility and Innovatus loan to …
Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update
GlobeNewswire
·
August 13, 2025
Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) ALPHA3 Proceeding as a Two-Arm Randomized Trial Comparing Cema-cel After Standard Fludarabine and Cyclophosphamide (FC …
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
GlobeNewswire
·
August 13, 2025
ROCKVILLE, MD, Aug. 13, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company developing innovative antibody-based therapeutics for the treatment of cancer, today announced that effective as of August 13, …
Elcora Provides Update on Status of Management Cease Trade Order
GlobeNewswire
·
August 13, 2025
HALIFAX, Nova Scotia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- ELCORA ADVANCED MATERIALS CORP. (TSX.V:ERA | Frankfurt:ELM | OTCQB – ECORF), (the "Company" or "Elcora"), is providing this update on the status of a management cease trade order granted on July 30, …
Emerita Announces Upsize to C$25M Brokered Private Placement Financing
GlobeNewswire
·
August 13, 2025
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (“Emerita” …